Agios PharmaceuticalsAGIO

那斯達克 · USD
35.00
+1.45
(+4.32%)
盤中 09/10 01:30 (UTC+8)
09/10 01:30 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.08
  • 0.09
  • 0.09
  • 0.11
  • 0.09
  • 0.12
  • 0.13
  • 0.20
  • 0.21
  • 0.45
icon
  • 15.29
  • 5.20
  • 4.05
  • 19.70
  • -18.68
  • 42.73
  • 3.41
  • 55.02
  • 3.90
  • 115.68
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
44,745
20,746
19,967
12,880
12,455
8,726
10,730
8,964
8,615
8,189
營業成本
2,9961,3191,8791,6791,7021,0851,2607831,495627
營業毛利
41,749
19,427
18,088
11,201
10,753
7,641
9,470
8,181
7,120
7,562
營業費用
152,301129,452139,666128,070137,809-----
研發費用
100,75481,14888,05686,79691,94072,74382,81072,45577,40168,620
推銷及管理費用
51,54748,30451,61041,27445,86941,52751,69738,53735,53631,014
非經常性項目費用
----------
其他營業費用
----------
營業利益
-110,552
-110,025
-121,578
-116,869
-127,056
-106,629
-125,037
-102,811
-105,817
-92,072
其他收入及費用
9,84910,91412,52313,43615,03617,34019,6381,103,8469,69910,523
利息費用
----------
稅前純益
-100,703
-99,111
-109,055
-103,433
-112,020
-89,289
-105,399
1,001,035
-96,118
-81,549
所得稅
---1,016----8,87653,120--
稅後純益
-100,703
-99,111
-108,039
-103,433
-112,020
-89,289
-96,523
947,915
-96,118
-81,549
基本每股稅後盈餘(元)
-1.69-1.69-1.86-1.78-1.93-1.55-1.6516.65-1.69-1.45
稀釋每股稅後盈餘(元)
-1.69-1.69-1.85-1.78-1.94-1.55-1.7416.52-1.69-1.45
基本平均股數(千股)
59488.0058782.0058358.0058139.0057932.0057459.0057105.0056939.0056802.0056383.00
稀釋平均股數(千股)
59488.0058782.0058358.0058139.0057932.0057459.0059940.0058432.0056802.0056383.00
還原基本每股稅後盈餘(元)
-1.69-1.69-1.86-1.78-1.93-1.55-1.6516.65-1.69-1.45
還原稀釋每股稅後盈餘(元)
-1.69-1.69-1.85-1.78-1.94-1.55-1.7416.52-1.69-1.45
還原基本平均股數(千股)
59,48858,78258,35858,13957,93257,45957,10556,93956,80256,383
還原稀釋平均股數(千股)
59,48858,78258,35858,13957,93257,45959,94058,43256,80256,383
EBITDA(千元)
-100,480-98,892-109,542-103,733-113,181-89,359-109,648998,646-97,134-82,728

大家都在看

HOT